TichyEM, HoffmanJM, TadrousM, et al.National trends in prescription drug expenditures and projections for 2024. Am J Health Syst Pharm, 2024; 81(14):583–598; doi: 10.1093/ajhp/zxae105
2.
KassabJG, TonkSS, LipshultzLI. Comparison of medicare reimbursement for common urologic and gynecologic procedures: An economic analysis of inflation-adjusted physician fees across a ten-year period. Urology, 2025:S0090; doi: 10.1016/j.urology.2025.04.060
3.
AnoushiravaniAA, HoveidaeiAH, SwartzGN, et al.Medicare Reimbursement Trends for Common Hip Arthroplasty Procedures: A Generational Perspective, 2006 to 2024. J Arthroplasty, 2025:S0883.
4.
The Late Career Health Scientist Group. The United States is facing unprecedented challenges in the field of health and health care: What can and should we do about it? A call to action. Annals of Behavioral Medicine, 2025; 59(1):kaaf030; doi: 10.1093/abm/kaaf030
5.
HuiD, De La RosaA, ChenJ, et al.State of palliative care services at US cancer centers: An updated national survey. Cancer, 2020; 126(9):2013–2023; doi: 10.1002/cncr.32738
6.
ChenJ, de la RosaA, LaiD, et al.Palliative medicine integration in the USA: Cancer centre executives’ attitudes. BMJ Support Palliat Care, 2023; 13(2):199–208; doi: 10.1136/bmjspcare-2020-002835
7.
BrueraE, NeumannCM, GagnonB, et al.Edmonton regional palliative care program: Impact on patterns of terminal cancer care. CMAJ, 1999; 161(3):290–293.
8.
BrueraE, NeumannCM, GagnonB, et al.The impact of a regional palliative care program on the cost of palliative care delivery. J Palliat Med, 2000; 3(2):181–186; doi: 10.1089/10966210050085241
9.
KaasaS, LogeJH, AaproM, et al.Integration of oncology and palliative care: A lancet oncology commission. Lancet Oncol, 2018; 19(11):e588–e653; doi: 10.1016/S1470-2045(18)30415-7
10.
DalalS, BrueraE. End-of-life care matters: Palliative cancer care results in better care and lower costs. Oncologist, 2017; 22(4):361–368; doi: 10.1634/theoncologist.2016-0277
